Covid-19 and non-communicable diseases: evidence from a systematic literature review

[1]  Vivek Bora,et al.  The Deadly Duo of COVID-19 and Cancer! , 2021, Frontiers in Molecular Biosciences.

[2]  Elias Mossialos,et al.  The impact of primary health care and specialist physician supply on amenable mortality in Mexico (2000-2015): Panel data analysis using system-Generalized Method of Moments. , 2021, Social science & medicine.

[3]  C. Jenkins,et al.  Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis , 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

[4]  E. Wherry,et al.  CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer , 2021, Research square.

[5]  E. Kandil,et al.  Asthma and COVID-19; different entities, same outcome: a meta-analysis of 107,983 patients , 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

[6]  R. Heidel,et al.  Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease , 2021, American journal of respiratory and critical care medicine.

[7]  L. Velloso,et al.  Asthma and COVID-19: a systematic review , 2021, Allergy, Asthma & Clinical Immunology.

[8]  A. Coolen,et al.  Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients , 2021, Cancer Cell.

[9]  Kwok-Kin Wong,et al.  Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis , 2020, Journal of the National Cancer Institute.

[10]  Jue Liu,et al.  Prevalence and impact of diabetes in patients with COVID-19 in China. , 2020, World journal of diabetes.

[11]  I. Cascorbi,et al.  Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions , 2020, Pharmacological Research.

[12]  K. Al-Wahaibi,et al.  Myocardial Injury Is Associated with Higher Morbidity and Mortality in Patients with 2019 Novel Coronavirus Disease (COVID-19) , 2020, SN Comprehensive Clinical Medicine.

[13]  M. Raviglione,et al.  The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region , 2020, European Respiratory Journal.

[14]  Md. Momin Islam,et al.  Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis , 2020, Journal of Community Health.

[15]  J. Soriano,et al.  Characteristics and Prognosis of COVID-19 in Patients with COPD , 2020, Journal of clinical medicine.

[16]  Lei Xu,et al.  History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case–control study , 2020, BMJ Open.

[17]  L. Zajdenverg,et al.  Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis , 2020, Diabetology & Metabolic Syndrome.

[18]  M. Marschollek,et al.  Risk factors for Covid-19 severity and fatality: a structured literature review , 2020, Infection.

[19]  G. Flaherty,et al.  COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations , 2020, Tropical Diseases, Travel Medicine and Vaccines.

[20]  A. Renzaho,et al.  The epidemiological burden and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis , 2020, Infection.

[21]  Md. Saiful Islam,et al.  Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis , 2020, Journal of global health.

[22]  M. Hauptmann,et al.  Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study , 2020, Clinical Microbiology and Infection.

[23]  Xiaotong Han,et al.  Clinical Characteristics and Prognosis of 218 Patients With COVID-19: A Retrospective Study Based on Clinical Classification , 2020, Frontiers in Medicine.

[24]  A. Eid,et al.  COVID-19 and diabetes mellitus: how one pandemic worsens the other , 2020, Reviews in Endocrine and Metabolic Disorders.

[25]  Jing Liu,et al.  Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis , 2020, Aging Clinical and Experimental Research.

[26]  Feng Wu,et al.  Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study , 2020, Diabetologia.

[27]  M. Santana,et al.  Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature , 2020, American Journal of Infection Control.

[28]  Xingfen Yang,et al.  A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis , 2020, Journal of Infection.

[29]  R. Bajpai,et al.  Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis , 2020, Diabetes Research and Clinical Practice.

[30]  M. Sepandi,et al.  Factors Associated with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis , 2020, Iranian journal of public health.

[31]  Yun Tang,et al.  Diabetes increases the mortality of patients with COVID-19: a meta-analysis , 2020, Acta Diabetologica.

[32]  Suheda Erener.  Diabetes, infection risk and COVID-19 , 2020, Molecular Metabolism.

[33]  A. Peters,et al.  Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[34]  J. Bousquet,et al.  Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review , 2020, International Archives of Allergy and Immunology.

[35]  K. Farsalinos,et al.  Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases , 2020, medRxiv.

[36]  J. Stingone,et al.  Asthma among hospitalized patients with COVID-19 and related outcomes , 2020, Journal of Allergy and Clinical Immunology.

[37]  V. Chinchilli,et al.  The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis , 2020, medRxiv.

[38]  S. Goyal,et al.  The Challenges of COVID-19 for People Living With Diabetes: Considerations for Digital Health , 2020, JMIR diabetes.

[39]  O. Morel,et al.  Impact of COVID-19 on the Cardiovascular System: A Review , 2020, Journal of clinical medicine.

[40]  Hong Liu,et al.  Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis , 2020, Aging and disease.

[41]  J. Alqahtani,et al.  Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis , 2020, Tropical medicine and infectious disease.

[42]  Xuexian Fang,et al.  Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis , 2020, Research.

[43]  R. Alizadeh-Navaei,et al.  Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis , 2020, The American Journal of Emergency Medicine.

[44]  Z. Dai,et al.  Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis , 2020, Journal of Clinical Virology.

[45]  Ritesh Gupta,et al.  Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[46]  L. Appel,et al.  The Relationship of COVID-19 Severity with Cardiovascular Disease and Its Traditional Risk Factors: A Systematic Review and Meta-Analysis , 2020, medRxiv.

[47]  Huihui Ren,et al.  Clinical characteristics and outcomes of patients with severe covid-19 with diabetes , 2020, BMJ Open Diabetes Research & Care.

[48]  R. Pranata,et al.  Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression , 2020, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[49]  C. Wang,et al.  Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China , 2020, Annals of Oncology.

[50]  A. Akbari,et al.  Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis , 2020, Archives of academic emergency medicine.

[51]  A. Paul,et al.  Asthma and COVID-19: What do we know now , 2020, Clinical medicine insights. Circulatory, respiratory and pulmonary medicine.

[52]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..